Literature DB >> 25824444

One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.

Karla Kerlikowske1, Charlotte C Gard2, Brian L Sprague3, Jeffrey A Tice4, Diana L Miglioretti5.   

Abstract

BACKGROUND: One measure of Breast Imaging Reporting and Data System (BI-RADS) breast density improves 5-year breast cancer risk prediction, but the value of sequential measures is unknown. We determined whether two BI-RADS density measures improve the predictive accuracy of the Breast Cancer Surveillance Consortium 5-year risk model compared with one measure.
METHODS: We included 722,654 women of ages 35 to 74 years with two mammograms with BI-RADS density measures on average 1.8 years apart; 13,715 developed invasive breast cancer. We used Cox regression to estimate the relative hazards of breast cancer for age, race/ethnicity, family history of breast cancer, history of breast biopsy, and one or two density measures. We developed a risk prediction model by combining these estimates with 2000-2010 Surveillance, Epidemiology, and End Results incidence and 2010 vital statistics for competing risk of death.
RESULTS: The two-measure density model had marginally greater discriminatory accuracy than the one-measure model (AUC, 0.640 vs. 0.635). Of 18.6% of women (134,404 of 722,654) who decreased density categories, 15.4% (20,741 of 134,404) of women whose density decreased from heterogeneously or extremely dense to a lower density category with one other risk factor had a clinically meaningful increase in 5-year risk from <1.67% with the one-density model to ≥1.67% with the two-density model.
CONCLUSION: The two-density model has similar overall discrimination to the one-density model for predicting 5-year breast cancer risk and improves risk classification for women with risk factors and a decrease in density. IMPACT: A two-density model should be considered for women whose density decreases when calculating breast cancer risk. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25824444      PMCID: PMC4452451          DOI: 10.1158/1055-9965.EPI-15-0035

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  27 in total

1.  Time-dependent ROC curves for censored survival data and a diagnostic marker.

Authors:  P J Heagerty; T Lumley; M S Pepe
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  Breast cancer risk reduction.

Authors:  Therese B Bevers; Deborah K Armstrong; Banu Arun; Robert W Carlson; Kenneth H Cowan; Mary B Daly; Irvin Fleming; Judy E Garber; Mary Gemignani; William J Gradishar; Helen Krontiras; Swati Kulkarni; Christine Laronga; Loretta Loftus; Deborah J Macdonald; Martin C Mahoney; Sofia D Merajver; Ingrid Meszoely; Lisa Newman; Elizabeth Pritchard; Victoria Seewaldt; Rena V Sellin; Charles L Shapiro; John H Ward
Journal:  J Natl Compr Canc Netw       Date:  2010-10       Impact factor: 11.908

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

4.  Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.

Authors:  Jack Cuzick; Jane Warwick; Elizabeth Pinney; Stephen W Duffy; Simon Cawthorn; Anthony Howell; John F Forbes; Ruth M L Warren
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

5.  Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study.

Authors:  Mary C Spayne; Charlotte C Gard; Joan Skelly; Diana L Miglioretti; Pamela M Vacek; Berta M Geller
Journal:  Breast J       Date:  2012-05-21       Impact factor: 2.431

6.  Reported mammographic density: film-screen versus digital acquisition.

Authors:  Jennifer A Harvey; Charlotte C Gard; Diana L Miglioretti; Bonnie C Yankaskas; Karla Kerlikowske; Diana S M Buist; Berta A Geller; Tracy L Onega
Journal:  Radiology       Date:  2012-12-18       Impact factor: 11.105

7.  Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.

Authors:  Jingmei Li; Keith Humphreys; Louise Eriksson; Gustaf Edgren; Kamila Czene; Per Hall
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

8.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

Review 9.  A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Authors:  Lydia E Pace; Nancy L Keating
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

10.  Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.

Authors:  D Gareth R Evans; Jane Warwick; Susan M Astley; Paula Stavrinos; Sarah Sahin; Sarah Ingham; Helen McBurney; Barbara Eckersley; Michelle Harvie; Mary Wilson; Ursula Beetles; Ruth Warren; Alan Hufton; Jamie C Sergeant; William G Newman; Iain Buchan; Jack Cuzick; Anthony Howell
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-11
View more
  11 in total

Review 1.  Breast Density Knowledge and Awareness: A Review of Literature.

Authors:  Marimer Santiago-Rivas; Shayna Benjamin; Lina Jandorf
Journal:  J Prim Care Community Health       Date:  2016-02-23

2.  Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition.

Authors:  Natalie J Engmann; Christopher Scott; Matthew R Jensen; Stacey J Winham; Lin Ma; Kathleen R Brandt; Amir Mahmoudzadeh; Dana H Whaley; Carrie B Hruska; Fang-Fang Wu; Aaron D Norman; Robert A Hiatt; John Heine; John Shepherd; V Shane Pankratz; Diana L Miglioretti; Karla Kerlikowske; Celine M Vachon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-11       Impact factor: 4.254

3.  Breast density scales: the metric matters.

Authors:  Mohamed Abdolell; Kaitlyn M Tsuruda; Peter Brown; Judy S Caines; Sian E Iles
Journal:  Br J Radiol       Date:  2017-09-08       Impact factor: 3.039

Review 4.  Assessing Risk of Breast Cancer: A Review of Risk Prediction Models.

Authors:  Geunwon Kim; Manisha Bahl
Journal:  J Breast Imaging       Date:  2021-02-19

5.  Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.

Authors:  Adam R Brentnall; Jack Cuzick; Diana S M Buist; Erin J Aiello Bowles
Journal:  JAMA Oncol       Date:  2018-09-13       Impact factor: 31.777

6.  Long-term excess risk of breast cancer after a single breast density measurement.

Authors:  Matejka Rebolj; Oleg Blyuss; Kee Seng Chia; Stephen W Duffy
Journal:  Eur J Cancer       Date:  2019-06-21       Impact factor: 9.162

7.  A systematic review and quality assessment of individualised breast cancer risk prediction models.

Authors:  Javier Louro; Margarita Posso; Michele Hilton Boon; Marta Román; Laia Domingo; Xavier Castells; María Sala
Journal:  Br J Cancer       Date:  2019-05-22       Impact factor: 7.640

8.  Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Authors:  Natalie J Engmann; Marzieh K Golmakani; Diana L Miglioretti; Brian L Sprague; Karla Kerlikowske
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

9.  Bayesian joint ordinal and survival modeling for breast cancer risk assessment.

Authors:  C Armero; C Forné; M Rué; A Forte; H Perpiñán; G Gómez; M Baré
Journal:  Stat Med       Date:  2016-08-14       Impact factor: 2.373

10.  Impact of Awareness of Breast Density on Perceived Risk, Worry, and Intentions for Future Breast Cancer Screening among Korean Women.

Authors:  Anh Thi Ngoc Tran; Ji Hae Hwang; Eunji Choi; Yun Yeong Lee; Mina Suh; Chan Wha Lee; Yeol Kim; Kui Son Choi
Journal:  Cancer Res Treat       Date:  2020-08-18       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.